The US District Court in Delaware has adopted Enzo's interpretation of patent language and rejected the defendants' argument to invalidate a key patent.
Luminex will pay Enzo Biochem $7.1 million to settle a lawsuit alleging infringement of patents for oligonucleotides and solid supports for fixed nucleic acids.
Hologic said in its Form 10-Q that Enzo sued the firm in March alleging infringement of a patent related to labeled nucleotides for use as diagnostic tools.
The appeals court reversed in part an earlier decision by aUSdistrict court that resulted in a $61 million award to Enzo, and remanded the case back to the district court.
The flow cytometry-based test is the first available for the firm's FlowScript platform and allows for the simultaneous analysis of multiple genes expressed in a single cell.
NEW YORK (GenomeWeb) – Enzo Biochem today said that PerkinElmer will pay the firm $7 million as part of a legal settlement reached between the firms last week.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
